Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exscientia Ltd ADR (NQ: EXAI )

7.960 +0.090 (+1.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 26, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 803,337
Open 7.950
Bid (Size) 7.760 (1)
Ask (Size) 8.250 (20)
Prev. Close 7.870
Today's Range 7.880 - 8.900
52wk Range 4.090 - 16.45
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Pharma Stocks That Will Boom Thanks to AI
Some pharma stocks to buy are benefiting from AI, but perhaps none more than these 3 that have developed deep platforms. 
Via InvestorPlace
Why Shares of Exscientia Soared This Week
The company benefited from a surge in interest in AI-associated stocks. 
Via The Motley Fool

Performance

YTD
+41.89%
+41.89%
1 Month
+56.08%
+56.08%
3 Month
+25.55%
+25.55%
6 Month
+43.17%
+43.17%
1 Year
-32.54%
-32.54%

More News

Read More
Why Artificial Intelligence Stock Exscientia Leaped 6% Higher Today
Via The Motley Fool
Exscientia: Q1 Earnings Insights
Via Benzinga
Exscientia Business Update for First Quarter 2023
From Exscientia plc
Via Business Wire
Exscientia Earnings Preview
Via Benzinga
Exscientia Highlights "The Future of AI-enabled Drug Discovery" at SLAS Europe
From Exscientia plc
Via Business Wire
A Preview Of Exscientia's Earnings
Via Benzinga
Earnings Scheduled For May 24, 2023
Via Benzinga
Exscientia to Report First Quarter 2023 Financial Results on May 24, 2023
From Exscientia plc
Via Business Wire
Exscientia Announces Sixth Molecule Created Through Generative AI Platform to Enter Clinical Stage
From Exscientia plc
Via Business Wire
Exscientia Appoints Harvard Professor Franziska Michor, Ph.D. to Board of Directors
From Exscientia plc
Via Business Wire
Data Presented at AACR 2023 Highlights Exscientia’s Clinical and Preclinical Development
From Exscientia plc
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
National Instruments, Nutex Health And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 23, 2023
Via Benzinga
Exscientia Business and Financial Update for the Full Year 2022
From Exscientia
Via Business Wire
Evogene Offers An Excellent Risk/Reward Ratio
Via Talk Markets
Exscientia to Report Full Year 2022 Financial Results on March 23, 2023
From Exscientia plc
Via Business Wire
Exscientia to Present Data Highlighting Pipeline and Precision Medicine Platform at AACR
From Exscientia plc
Via Business Wire
Exscientia Announces Expansion of its Precision Oncology Pipeline
From Exscientia plc
Via Business Wire
Exscientia Announces Collaboration with Charité to Advance Development of Precision Medicine Platform
From Exscientia plc
Via Business Wire
Exscientia to Present at Upcoming Investor Conferences in March
From Exscientia plc
Via Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.